Jaguar Health (JAGX) EBT (2014 - 2026)
Jaguar Health (JAGX) posted quarterly EBT of $8.7 million for Q1 2026, up 182.32% year-over-year from $3.1 million in Q1 2025, and up 137.61% quarter-over-quarter from -$23.2 million in Q4 2025.
Jaguar Health (JAGX) EBT (2014 - 2026) Analysis & Trends
Jaguar Health (JAGX) has reported EBT for 13 consecutive years, with $8.7 million the latest figure, recorded in Q1 2026.
- In Q1 2026, EBT rose 182.32% year-over-year to $8.7 million; the TTM figure through Mar 2026 stood at -$34.7 million (up 14.33% YoY), while the FY2025 annual figure was -$54.0 million, down 37.57% from the prior year.
- EBT grew to $8.7 million in Q1 2026 per JAGX's latest filing, from -$23.2 million in the prior quarter.
- Across five years, EBT topped out at $8.7 million in Q1 2026 and bottomed at -$23.2 million in Q4 2025.
- Historically, EBT has averaged -$10.3 million across 5 years, with a median of -$10.0 million in 2024.
- Annual changes were most pronounced in 2025 — EBT slumped 126.63% — and 2026, when it soared 182.32%.
- Jaguar Health's EBT stood at -$8.2 million in 2022, then slipped by 13.08% to -$9.3 million in 2023, then fell by 9.94% to -$10.2 million in 2024, then plunged by 126.63% to -$23.2 million in 2025, then soared by 137.61% to $8.7 million in 2026.
- Business Quant data shows JAGX's EBT at $8.7 million in Q1 2026, -$23.2 million in Q4 2025, and -$9.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 1.39 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 1.53 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 541.00 Mn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | -767.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 312.46 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 177.81 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -11.37 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 81.49 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -264.70 Mn |
| 10 | Jaguar Health | 452,552.38 | -9.61 Mn | 19.11 Mn | 8.72 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 8.72 Mn |
| Dec 31, 2025 | -23.19 Mn |
| Sep 30, 2025 | -9.65 Mn |
| Jun 30, 2025 | -10.56 Mn |
| Mar 31, 2025 | -10.60 Mn |
| Dec 31, 2024 | -10.23 Mn |
| Sep 30, 2024 | -10.02 Mn |
| Jun 30, 2024 | -9.63 Mn |
| Mar 31, 2024 | -9.37 Mn |
| Dec 31, 2023 | -9.31 Mn |
| Sep 30, 2023 | -7.90 Mn |
| Jun 30, 2023 | -12.29 Mn |
| Mar 31, 2023 | -12.40 Mn |
| Dec 31, 2022 | -8.23 Mn |
| Sep 30, 2022 | -12.61 Mn |
| Jun 30, 2022 | -9.39 Mn |
| Mar 31, 2022 | -18.16 Mn |
| Dec 31, 2021 | -14.32 Mn |
| Sep 30, 2021 | -12.19 Mn |
| Jun 30, 2021 | -14.08 Mn |